A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of this study is to assess the time for patients to relapse when switched from an oral antipsychotic to one of two doses of long-acting risperidone injection (shots). Risperidone has been used successfully to treat schizophrenia and schizoaffective disorder.
Epistemonikos ID: b1ab5d9d3b3347897d83b203127a5717d613d339
First added on: May 04, 2024